Brief: Cumberland Pharma Reports Qtrly Revenue Of $8.3 Mln
08/03/2022 23:08
March 8 (Reuters) - Cumberland Pharmaceuticals Inc CPIX.O :
* QUARTERLY REVENUE $8.3 MILLION
* ADJUSTED EARNINGS FOR Q4 LOSS $1.9 MILLION VERSUS NET LOSS
OF
$4.4 MILLION
Source text for Eikon: ID:nPn124vCFa
Further company coverage: CPIX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cumberland Pharmaceuticals
See all newsBrief: Cumberland Pharmaceuticals Announces Assist-Ssc Trial Top-Line Results
Cumberland Pharmaceuticals Q2 loss widens after Apotex transaction
Brief: Cumberland Pharmaceuticals Announces Special Dividend Of $1.50 Per Share
Cumberland Pharmaceuticals Q1 revenue up 5%; to sell FDA‑approved brands to Apotex for $100 mln
NASDAQ RESUMED AT 09:38 AM